Managed Care Review of Unmet Medical Needs, New Treatments, and Health Economics Associated with Schizophrenia - Payer Forum

https://www.pharmacytimes.org/on-demand/a-managed-care-review-of-unmet-medical-needs-new-treatments-and-health-economics-associated-with-schizophrenia

Related Videos

Related Content

Advertisement

July 26th 2024

Immunotherapy for Angiosarcoma: Promising Results for Scalp and Face Tumors

Sabrina Serani

The Alliance AO91902 trial investigated whether adding immunotherapy to chemotherapy would improve outcomes for patients with advanced angiosarcoma.

July 25th 2024

Dr Jason Spangler on Enhancing Equity in Health Technology Assessment

Brooke McCormick

On this episode of Managed Care Cast, we're talking with Jason Spangler, MD, MPH, CEO of the Center for Innovation and Value Research on equity challenges within health technology assessment.

July 26th 2024

Potential Biomarkers Predict Disease Severity and Treatment Response in SMA

Kyle Munz

Results from a single-center, observational, prospective study suggested that inflammatory markers could predict disease severity and treatment efficacy for patients with spinal muscular atrophy (SMA).

July 23rd 2024

Frameworks for Advancing Health Equity: Health Equity by Design

Giuliana Grossi

Melissa Clarke, MD, CMQ, the chief health equity officer at Elevance Health, explains "Health Equity by Design" and how Elevance Health is committed to ensuring a personalized and intentional approach for all its members.

July 26th 2024

FDA Approves Deuruxolitinib for Alopecia Areata

Cameron Santoro

The FDA has approved deuruxolitinib, an oral medication developed by Sun Pharma, as the first-line treatment for adults with moderate to severe alopecia areata.

July 26th 2024

AJMC® in the Press, July 26, 2024

AJMC Staff

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

Related Content

Advertisement

July 26th 2024

Immunotherapy for Angiosarcoma: Promising Results for Scalp and Face Tumors

Sabrina Serani

The Alliance AO91902 trial investigated whether adding immunotherapy to chemotherapy would improve outcomes for patients with advanced angiosarcoma.

July 25th 2024

Dr Jason Spangler on Enhancing Equity in Health Technology Assessment

Brooke McCormick

On this episode of Managed Care Cast, we're talking with Jason Spangler, MD, MPH, CEO of the Center for Innovation and Value Research on equity challenges within health technology assessment.

July 26th 2024

Potential Biomarkers Predict Disease Severity and Treatment Response in SMA

Kyle Munz

Results from a single-center, observational, prospective study suggested that inflammatory markers could predict disease severity and treatment efficacy for patients with spinal muscular atrophy (SMA).

July 23rd 2024

Frameworks for Advancing Health Equity: Health Equity by Design

Giuliana Grossi

Melissa Clarke, MD, CMQ, the chief health equity officer at Elevance Health, explains "Health Equity by Design" and how Elevance Health is committed to ensuring a personalized and intentional approach for all its members.

July 26th 2024

FDA Approves Deuruxolitinib for Alopecia Areata

Cameron Santoro

The FDA has approved deuruxolitinib, an oral medication developed by Sun Pharma, as the first-line treatment for adults with moderate to severe alopecia areata.

July 26th 2024

AJMC® in the Press, July 26, 2024

AJMC Staff

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.